Dr. Raminderpal Singh is a recognised KOL (key opinion leader) in the techbio industry. He has over 30 years of global experience – leading and advising teams building computational modeling systems that are both cost-efficient and have significant IP value. His passion is to help early to mid-stage life sciences companies achieve novel biological breakthroughs through the effective use of computational algorithms.
Raminderpal is currently the CEO and co-Founder of Incubate bio – a techbio providing a service to life sciences companies who are looking to accelerate their research and lower their wet lab costs through in silico modeling. Incubate bio’s technology (ALaSCA) applies causal analysis and machine learning to uncover drivers in biological systems (such as protein networks), using multi-omics and phenotypic (and clinical) data. Raminderpal also advises several early-stage life sciences and healthtech startups.
Raminderpal has extensive experience building businesses in both Europe and the US. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.
Raminderpal earned his PhD in semiconductor modeling in 1997. He has published several papers and two books, and he has twelve issued patents. In 2003, he was selected by EETimes as one of the top 13 most influential people in the semiconductor industry.